Glaxo Wellcome UK Ltd
Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed
||1 x 60 doses
||29 August 2017
Brief description of the problem
Glaxo Wellcome UK Limited is recalling the above Lot of Seretide Accuhaler 50/250mcg because a manufacturing issue with this Lot has been identified which has resulted in a small number of units not delivering the full number of doses.
Please note, this is not a patient level recall.
Advice for healthcare professionals
Please quarantine any remaining stock of this Lot and return to the original supplier for credit.
The location of Lot number and expiry is as shown in the images in the document below.
Advice for wholesalers
Quarantine any remaining stock of this Lot and return to the original supplier for credit.
Medical information enquiries
Please contact GSK via email@example.com, Live Chat facility or by calling 0800 221 441 (option 4).
please refer to the GSK website or contact 0800 221 441 (option 1).
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to relevant clinics, hospitals, mental health trusts, general practitioners and community pharmacists for information.
Published 21 February 2018